Purpose

The purpose of this study is to find out if an anxiety treatment program is practical and effective for Latino older adults with cancer (OACs) and their caregivers.

Conditions

Eligibility

Eligible Ages
Over 40 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

Older Adults with Cancer (OAC) - As per medical record or self-report, is currently age 65 years or older - As per medical record or self-report, currently receiving active cancer treatment OR is within eighteen months of completing active treatment which includes surgery, chemotherapy, radiation, and immunotherapy. - As per self-report, identifies as Latino and/or Hispanic Ethnicity - Per self-report, has a primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) age 40 or older who is willing and able to participate in the study ; if a patient does not have a primary informal caregiver or if the caregiver does not or cannot participate, but meets all other inclusion criteria they will be allowed to enroll in the study - Scores ≥6 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS) - Per self-report, fluent in English and/or Spanish** ** Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify language fluency necessary for participation in the study: 1. How well do you speak English and/or Spanish? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused) 2. What is your preferred language for healthcare? (must respond English and/or Spanish) Caregiver - Per OAC report, is primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) for the eligible OAC patient - As per self-report, is age 40 years or older - Per self-report, fluent in English and/or Spanish** ** Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify language fluency necessary for participation in the study: 1. How well do you speak English and/or Spanish? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused) 2. What is your preferred language for healthcare? (must respond English and/or Spanish)

Exclusion Criteria

OAC - As per medical record or self-report, currently receiving psychotherapy - As per medical record or self-report, taking psychotropic medications for < 8 weeks prior to MAC Session 1 and/or anticipates changing their medication during the study - As per medical record or self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder - Severely cognitively impaired as demonstrated by Blessed Orientation Memory Concentration score ≥ 9 - Per research staff judgment and/or self-report, too ill or weak to complete study procedures - Per medical record or self-report, receiving hospice care at the time of enrollment Caregiver - As per self-report, currently receiving psychotherapy - As per self-report, taking psychotropic medications for < 8 weeks prior to MAC Session 1 and/or anticipates changing their medication during the study - As per self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder - Severely cognitively impaired as demonstrated by Blessed Orientation Memory Concentration score ≥ 11 - Per research staff judgment and/or self-report, too ill or weak to complete study procedures

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Supportive Care
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Latino caregivers and the Latino older adults with cancer (OACs)
The intervention, MAC, is a seven-session (45- 60 minutes per session) psychotherapy intervention delivered via videoconference and/or telephone by licensed social workers. All sessions will be audio-recorded. MAC content, structure, and length are consistent with core components of cognitive behavioral therapy (CBT) (Freeman, 2004).
  • Other: Managing Anxiety from Cancer (MAC)
    The intervention, MAC, is a seven-session (45-60 minutes per session) psychotherapy intervention delivered via videoconference. and/or telephone by licensed social workers

Recruiting Locations

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities)
Basking Ridge 5095409, New Jersey 5101760 07920
Contact:
Kelly McConnell, PhD
646-888-0026

Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown 5101170, New Jersey 5101760 07748
Contact:
Kelly McConnell, PhD
646-888-0026

Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale 5101361, New Jersey 5101760 07645
Contact:
Kelly McConnell, PhD
646-888-0026

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Commack 5113412, New York 5128638 11725
Contact:
Kelly McConnell, PhD
646-888-0026

Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison 5120095, New York 5128638 10604
Contact:
Kelly McConnell, PhD
646-888-0026

Memorial Sloan Kettering Cancer Center (All protocol activities)
New York 5128581, New York 5128638 10065
Contact:
Kelly McConnell, PhD
646-888-0026

Memorial Sloan Kettering Nassau (All Protocol Activities)
Rockville Centre 5134203, New York 5128638 11553
Contact:
Kelly McConnell, PhD
646-888-0026

More Details

Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

Kelly McConnell, PhD
646-888-0026
mcconnek@mskcc.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.